Development of a Mobile Health Personalized Physiologic Analytics Tool for Pediatric Patients with Sepsis
Development of a Mobile Health Personalized Physiologic Analytics Tool for Pediatric Patients with Sepsis
批准号:
10878034
负责人:
Stephanie Chow Garbern
金额:
$16.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-10 至 2025-04-30
关键词:
AffectAreaAwardBolus InfusionCellular PhoneCessation of lifeChildChildhoodClinicalCritical CareDangerousnessDataDevelopmentDiagnosticDiarrheaDiseaseEquipmentGeographic LocationsHealthcare SystemsIV FluidImmune responseInfectionLaboratoriesLifeLiquid substanceMalariaMalnutritionMonitorMultiple Organ FailureNormal salineOrgan failureParentsPatient-Focused OutcomesPhysiologicalPneumoniaPopulationPractice ManagementResearchResource-limited settingResourcesSepsisSeveritiesSubgroupTechnologyTimeVeinsacute infectionanalytical toolantimicrobial drugimproved outcomeindividualized medicineintravenous administrationlow and middle-income countrieslow income countrymHealthmachine learning modelmortalitymortality risknovelnutritionpediatric patientspediatric sepsispredictive modelingpreventseptic patientstemporal measurementtooltransmission processtreatment responsetreatment strategywearable device
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Sepsis is a life-threatening condition caused by an imbalanced immune response to infection, leading to organ
failure and death if untreated. Low- and middle-income countries (LMICs) bear a disproportionate burden of
childhood deaths due to sepsis resulting from acute infections like pneumonia, diarrhea, and malaria. Timely
recognition and treatment of sepsis in children are crucial for altering the disease course and preventing
mortality. There is immense potential for novel clinical tools that can expedite the identification of severe
sepsis, multiple organ dysfunction syndrome (MODS), and predict the highest mortality risk. These tools can
also effectively monitor treatment responses, decreasing the need for expensive laboratory diagnostics and
critical care monitoring equipment used in high-resource settings.
While early initiation of antimicrobial drugs is well-established in sepsis treatment, the guidance for
administration of intravenous fluids (IVF) for treatment of severe sepsis can vary depending on the
geographical region and even nutrition status. The 2020 Surviving Sepsis Campaign advises that children who
reside in areas with resource-limited healthcare systems receive lower initial fluid volumes based for sepsis
treatment based on a study with narrow generalizability that demonstrated increased mortality rates among
pediatric patients who received normal saline boluses for severe sepsis. Children with malnutrition and severe
sepsis are also fluid restricted.
This project aims to leverage predictive modeling and mobile health (mHealth) tools to evaluate the impact of
IVF administration on sepsis severity in pediatric patients. By utilizing machine learning models developed
under the parent award, real-time analysis of IVF effects on sepsis severity can be performed in LMIC settings.
Utilizing continuous vital sign parameters transmitted from a wearable device to a mobile phone, real-time
measurement of IVF impact on sepsis severity can be determined. This research can shed light on the benefits
or harms of fluid administration in LMIC children with severe sepsis, including specific populations like
malnourished children. Given the limited studies on appropriate fluid volumes for this subgroup, this research
offers an opportunity to determine safe and optimal fluid administration practices.
Through this research, we aim to contribute to the understanding of IVF administration effects on sepsis
severity in children, particularly in LMIC settings. The findings can guide fluid management practices, inform
tailored treatment strategies for malnourished patients, and improve outcomes for pediatric sepsis patients
worldwide.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a Mobile Health Personalized Physiologic Analytics Tool for Pediatric Patients with Sepsis
-
批准号:10880477
-
项目类别:
-
资助金额:$24.71万
-
财政年份:2021
-
负责人:Stephanie Chow Garbern
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: